Tetsuhiro Chiba Selected Research

Thrombocytopenia (Thrombopenia)

8/2014	A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
8/2014	Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
1/2014	Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuhiro Chiba Research Topics

Disease

60	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2003
40	Neoplasms (Cancer) 09/2022 - 12/2003
7	Infections 01/2020 - 02/2003
7	Liver Diseases (Liver Disease) 02/2018 - 06/2005
5	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 03/2018 - 01/2013
3	Liver Neoplasms (Liver Cancer) 09/2022 - 04/2018
3	Adenocarcinoma 04/2021 - 07/2012
3	Multiple Myeloma 01/2021 - 08/2017
3	Neutropenia 10/2020 - 08/2014
3	Fibrosis (Cirrhosis) 01/2020 - 10/2015
3	Ascites 01/2020 - 06/2015
3	Chronic Hepatitis C 02/2018 - 01/2014
3	Liver Failure 01/2018 - 02/2004
3	Hepatitis B 01/2018 - 09/2003
3	Thrombocytopenia (Thrombopenia) 08/2014 - 01/2014
3	Hyperbilirubinemia 08/2014 - 05/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2005 - 12/2002
2	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2020
2	Disease Progression 01/2022 - 01/2016
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 05/2012
2	Anemia 10/2020 - 08/2014
2	Leukopenia 10/2020 - 08/2014
2	Stomach Neoplasms (Stomach Cancer) 09/2020 - 01/2014
2	Chronic Hepatitis B 01/2020 - 01/2013
2	Anorexia 01/2018 - 01/2015
2	Diabetes Mellitus 01/2018 - 01/2013
2	Fistula 01/2017 - 09/2014
2	Fatty Liver 01/2017 - 09/2002
2	Brain Diseases (Brain Disorder) 01/2017 - 06/2015
2	Exanthema (Rash) 08/2014 - 09/2011
2	Hyponatremia 08/2014 - 08/2014
2	Hepatitis 02/2003 - 12/2002
1	Microsatellite Instability 11/2021
1	Circulating Neoplastic Cells 04/2021

Drug/Important Bio-Agent (IBA)

18	Sorafenib (BAY 43-9006)FDA Link 11/2021 - 09/2011
7	InterferonsIBA 09/2020 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 09/2022 - 06/2015
6	Alanine Transaminase (SGPT)IBA 08/2014 - 02/2011
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 12/2003
4	Antiviral Agents (Antivirals)IBA 11/2018 - 02/2004
4	BilirubinIBA 04/2018 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 03/2018 - 09/2009
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2014 - 09/2011
3	Pharmaceutical PreparationsIBA 10/2022 - 09/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2020
3	lenvatinibIBA 09/2021 - 08/2020
3	Metformin (Glucophage)FDA LinkGeneric 12/2013 - 07/2012
3	Complementary DNA (cDNA)IBA 09/2004 - 12/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2021
2	UNC1999IBA 11/2021 - 08/2017
2	Proteasome InhibitorsIBA 01/2021 - 08/2017
2	regorafenibIBA 01/2020 - 01/2018
2	entecavir FDA Link 01/2020 - 01/2013
2	Tolvaptan FDA Link 01/2020 - 10/2015
2	Polycomb Repressive Complex 2IBA 12/2019 - 08/2017
2	Serum AlbuminIBA 04/2018 - 01/2014
2	RNA (Ribonucleic Acid)IBA 03/2018 - 08/2017
2	gadolinium ethoxybenzyl DTPA FDA Link 04/2017 - 06/2013
2	Histone-Lysine N-MethyltransferaseIBA 03/2017 - 01/2015
2	Epithelial Cell Adhesion MoleculeIBA 01/2017 - 01/2013
2	Capsules (Microcapsules)IBA 01/2017 - 01/2013
2	nasIBA 01/2016 - 01/2013
2	perfluorobutane (AI 700)IBA 12/2015 - 01/2014
2	miriplatinIBA 01/2015 - 12/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2014 - 01/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 06/2012
2	Fetal Proteins (Fetoprotein)IBA 01/2013 - 02/2011
2	Lamivudine (Epivir)FDA Link 01/2013 - 06/2005
2	Decitabine FDA Link 06/2006 - 12/2003
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2005 - 02/2003
2	Histones (Histone)IBA 05/2005 - 01/2004
2	HGF activatorIBA 05/2005 - 12/2003
2	Messenger RNA (mRNA)IBA 04/2005 - 09/2004
2	trichostatin A (A 300)IBA 09/2004 - 01/2004
2	theasinensin AIBA 09/2004 - 01/2004
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2004 - 01/2004
1	Cholic AcidIBA 10/2022
1	FructoseIBA 10/2022
1	CholesterolIBA 10/2022
1	GelatinIBA 09/2022
1	Monoclonal AntibodiesIBA 01/2022
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	atezolizumabIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	pembrolizumabIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 04/2021

Therapy/Procedure

25	Therapeutics 09/2022 - 02/2004
9	Radiofrequency Ablation 02/2021 - 01/2013
5	Drug Therapy (Chemotherapy) 01/2019 - 12/2013
5	Transplantation 02/2011 - 09/2003
3	Liver Transplantation 10/2021 - 11/2005
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2005 - 12/2002
2	Retreatment 03/2018 - 01/2018
2	Microbubbles 12/2015 - 01/2014
2	Craniotomy 01/2014 - 01/2013
1	Precision Medicine 09/2022
1	Punctures 09/2022
1	Immunotherapy 01/2022